中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Nardostachys jatamansi and levodopa combination alleviates Parkinson's disease symptoms in rats through activation of Nrf2 and inhibition of NLRP3 signaling pathways

文献类型:期刊论文

作者Li, Jiayuan1; Yu, Jiahe1; Guo, Jianyou2; Liu, Jinfeng1; Wan, Guohui1; Wei, Xiaojia1; Yang, Xue1; Shi, Jinli1,3
刊名PHARMACEUTICAL BIOLOGY
出版日期2023-12-31
卷号61期号:1页码:1175-1185
通讯作者邮箱shijl@bucm.edu.cn (jinli shi)
ISSN号1388-0209
关键词Dyskinesia neurotransmitters dopaminergic neurons nardosinone molecular docking oxidative stress neuroinflammation >
DOI10.1080/13880209.2023.2244176
产权排序2
文献子类实证研究
英文摘要

Context Levodopa combined with traditional Chinese medicine has a synergistic effect on Parkinson's disease (PD). Recently, we demonstrated that Nardostachys jatamansi (D. Don) DC. [syn. Patrinia jatamansi D.Don, N. grandiflora DC.] (Valerianaceae) (NJ) can alleviate PD. Objective To explore the synergistic effect of NJ combined with levodopa against PD. Materials and methods The PD model was established by injecting rotenone. Eighty-four Sprague-Dawley rats were randomly divided into seven groups: sham, model, different doses of NJ (0.31, 0.62, or 1.24 g/kg) combined with levodopa (25 mg/kg), and levodopa alone (25 and 50 mg/kg) groups. The synergistic effect of the combination was investigated by pharmacodynamic investigation and detection of expression of nuclear factor erythro2-related factor 2 (Nrf2) and NLR family proteins containing Pyrin-related domain 3 (NLRP3) pathways. Results Compared with the model group, NJ + levodopa (1.24 g/kg + 25 mg/kg) increased the moving distance of PD rats in the open field (2395.34 & PLUSMN; 668.73 vs. 1501.41 & PLUSMN; 870.23, p < 0.01), enhanced the stay time on the rotating rod (84.86 & PLUSMN; 18.15 vs. 71.36 & PLUSMN; 17.53, p < 0.01) and the combination was superior to other treatments. The synergistic effects were related to NJ + levodopa (1.24 g/kg + 25 mg/kg) increasing the neurotransmitter levels by 38.80%-88.67% in PD rats, and inhibiting oxidative stress and NLRP3 pathway by activating Nrf2 pathway. Discussion and conclusions NJ combined with levodopa is a promising therapeutic candidate for PD, which provides a scientific basis for the subsequent clinical combination therapy of levodopa to enhance the anti-PD effect.

收录类别SCI
WOS关键词OXIDATIVE STRESS ; ROTENONE ; DOPAMINE
资助项目National Natural Science Foundation of China[82073971] ; National Science and Technology Major Special Project[2020071720300]
WOS研究方向Plant Sciences ; Medical Laboratory Technology ; Pharmacology & Pharmacy
出版者TAYLOR & FRANCIS LTD
WOS记录号WOS:001044797500001
资助机构National Natural Science Foundation of China ; National Science and Technology Major Special Project
源URL[http://ir.psych.ac.cn/handle/311026/45840]  
专题心理研究所_中国科学院心理健康重点实验室
通讯作者Shi, Jinli
作者单位1.Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China
2.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China
3.Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing 102488, Peoples R China
推荐引用方式
GB/T 7714
Li, Jiayuan,Yu, Jiahe,Guo, Jianyou,et al. Nardostachys jatamansi and levodopa combination alleviates Parkinson's disease symptoms in rats through activation of Nrf2 and inhibition of NLRP3 signaling pathways[J]. PHARMACEUTICAL BIOLOGY,2023,61(1):1175-1185.
APA Li, Jiayuan.,Yu, Jiahe.,Guo, Jianyou.,Liu, Jinfeng.,Wan, Guohui.,...&Shi, Jinli.(2023).Nardostachys jatamansi and levodopa combination alleviates Parkinson's disease symptoms in rats through activation of Nrf2 and inhibition of NLRP3 signaling pathways.PHARMACEUTICAL BIOLOGY,61(1),1175-1185.
MLA Li, Jiayuan,et al."Nardostachys jatamansi and levodopa combination alleviates Parkinson's disease symptoms in rats through activation of Nrf2 and inhibition of NLRP3 signaling pathways".PHARMACEUTICAL BIOLOGY 61.1(2023):1175-1185.

入库方式: OAI收割

来源:心理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。